All SARS-CoV-2 articles – Page 2
-
NewsComputer-identified antiviral drug candidates confirmed by lab experiments
An interdisciplinary research team has identified two antiviral drug candidates effective against a wide range of viruses. The study demonstrates how combining computer-aided modeling with laboratory validation can speed up the development of new antiviral drugs.
-
NewsResearchers develop paper-based diagnostic tool for rapid, affordable infectious disease detection
A team of scientists has developed a breakthrough paper-based diagnostic device that can detect COVID-19 and other infectious diseases in under 10 minutes, without the need for sophisticated lab equipment or trained personnel.
-
NewsNew mRNA vaccine is more effective and less costly to develop, Pitt study finds
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study.
-
NewsNew diagnostic tool uses bioluminescence to detect viruses
Researchers are shining a powerful new light into the viral darkness with the development of Luminescence CAscade-based Sensor (LUCAS), a rapid, portable, highly-sensitive diagnostic tool for processing complex biological samples.
-
NewsYeast produces human DNase1 for the first time
The protein DNase1 is used to treat cystic fibrosis but it takes considerable effort and cost to produce it in immortalized hamster cells. Researchers have now produced it in yeast cells for the first time.
-
NewsMicrobial proteins reveal chemical signatures of body sites and inflammation
A new study shows that protein sequences associated with microbial communities in the human gut have uniquely low stoichiometric water content and undergo counterintuitive chemical shifts toward chemically reduced states during inflammation.
-
NewsDisrupting the residual triggers of COVID-19 in patients with long COVID
Spatial transcriptomics reveals activation of SARS-CoV-2-related signaling pathways in the epipharynx of patients with long COVID.
-
NewsKIST develops multifunctional peptide that fights viruses and promotes wound healing
Researchers announced that they have developed a therapeutic substance with both antiviral and tissue regenerative properties, based on a peptide derived from natural sources.
-
NewsSARS-CoV-2 corrupts some white blood cells to suppress immune system, suggesting path to severe COVID
A study found that neutrophils may be altered by SARS-CoV-2, the virus that causes COVID-19, to cease their normal function of destroying pathogens in the body and, instead, significantly inhibit other immune cells critical for fighting the virus.
-
CareersHow structural imaging is revolutionising vaccines
Dr. Peijun Zhang, Director of the Electron Bio-Imaging Centre (eBIC) at the UK’s national synchrotron facility Diamond Light Source, reveals how Cryo-ET is powering some of the most important advances in vaccine research.
-
NewsPost-COVID syndrome: new insights into connection between gut health and fatigue
A new study shows that post-COVID syndrome patients have altered inflammatory markers and a disturbed intestinal barrier, which could contribute to the development of post-viral fatigue.
-
NewsEngineered bacteria can deliver antiviral therapies and vaccines
New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines.
-
NewsA gene variant increases the risk of long COVID
An international team of researchers has found a genetic link to long-term symptoms after COVID-19. The identified gene variant is located close to the FOXP4 gene, which is known to affect lung function.
-
NewsResearchers reveal remarkable antimicrobial activity in hydrogen boride nanosheets
Hydrogen boride (HB) nanosheets represent an exciting new frontier in the search for technologies that can combat microbes in everyday settings. Researchers discovered that they exhibit excellent antibacterial, antiviral, and antifungal properties.
-
NewsAI-powered framework predicts the evolutionary fitness of SARS-CoV-2 variants
CoVFit is a novel framework designed to predict the fitness of SARS-CoV-2 variants. It integrates molecular data with large-scale epidemiological data to provide a predictive model that helps us understand why some variants succeed while others do not.
-
NewsSegregation fuels faster spread of infectious diseases, study finds
Structural inequalities, including wealth inequality and social segregation, not only make certain groups more vulnerable during public health crises but also accelerate the spread of infectious diseases through society, according to a team of international researchers.
-
NewsWorld Health Assembly adopts historic Pandemic Agreement to make the world more equitable and safer from future pandemics
Member States of the World Health Organization (WHO) today formally adopted by consensus the world’s first Pandemic Agreement, following more than three years of intensive negotiations launched by governments in response to the COVID-19 pandemic.
-
NewsScientists find two brain biomarkers in long COVID sufferers may be what’s causing brain fog
A new study that compares inflammation and brain stress responses in long COVID-19 patients with individuals who have fully recovered shows those with cognitive issues have a lower ability to adapt to stress and higher levels of inflammation in their brains.
-
NewsWorld’s largest bat organoid platform paves the way for pandemic preparedness
Researchers have created the world’s most comprehensive bat organoid platform. These ’mini-organs’ are grown from five common bat species found across Asia and Europe and represent four different organs—airway, lungs, kidneys, and small intestine.
-
NewsNew study offers insights into designing safe, effective nasal vaccines
Researchers found that nasal vaccine boosters can trigger strong immune defenses in the respiratory tract, even without the help of immune-boosting ingredients known as adjuvants. The findings, researchers suggest, may offer critical insights into developing safer, more effective nasal vaccines in the future.